Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

GB2064 (lenumlostat) shows preliminary evidence of bone marrow collagen fibrosis reduction with manageable tolerability in JAK inhibitor-refractory myelofibrosis: results from the MYLOX-1 phase IIa study

Department of Hematology, Oncology, and Rheumatology, Heidelberg University Hospital, Germany
Guy's and St Thomas' NHS Foundation Trust, London, UK
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano
Azienda Ospedaliero-Universitaria San Luigi Gonzaga, Orbassano
Memorial Sloan Kettering, New York
Academic Specialist Center, ACT; Australian National University, Canberra, Australia
Galecto Inc, Copenhagen, Denmark
Galecto Inc, Copenhagen, Denmark
Galecto Inc, Copenhagen, Denmark
Galecto Inc, Copenhagen, Denmark
Galecto Inc, Copenhagen, Denmark
Galecto Inc, Kuala Lumpur, Malaysia
Icahn School of Medicine at Mount Sinai, New York
Haematologica Early view Mar 5, 2026 https://doi.org/10.3324/haematol.2025.289108

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.289108
 
Published
2026-03-05
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2026 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

No Data Yet

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2026 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online